News
-
-
PRESS RELEASE
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap, with a target price of €3.20 and a potential upside of 87% according to the study 'Du baume au coeur'. The coverage adds to the financial analyst consensus -
-
PRESS RELEASE
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence.
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence in Prague, Czech Republic. The innovative medical device offers hope for the estimated 400 million patients affected worldwide -
-
-
PRESS RELEASE
Affluent Medical : Excellent valve performance at 1 year follow up and rising recognition of Epygon biomimetic mitral valve.
Affluent Medical reports excellent valve performance and increasing recognition of Epygon biomimetic mitral valve, as published in a peer-reviewed journal. The innovative device aims to enhance cardiac performance and patient outcomes -
PRESS RELEASE
Affluent Medical closes €3.5 million bridge via capital increase from key shareholders.
Affluent Medical closes €3.5 million bridge via capital increase from key shareholders. The transaction enables the company to continue exploring options for securing long-term financing and executing critical milestones. The bridge financing extends financial runway until May 2024 without impacting operational activities -
-
